Literature DB >> 23997354

Health Insurance as a Two-Part Pricing Contract.

Darius Lakdawalla1, Neeraj Sood.   

Abstract

Monopolies appear throughout health care. We show that health insurance operates like a conventional two-part pricing contract that allows monopolists to extract profits without inefficiently constraining quantity. When insurers are free to offer a range of insurance contracts to different consumer types, health insurance markets perfectly eliminate deadweight losses from upstream health care monopolies. Frictions limiting the sorting of different consumer types into different insurance contracts restore some of these upstream monopoly losses, which manifest as higher rates of uninsurance, rather than as restrictions in quantity utilized by insured consumers. Empirical analysis of pharmaceutical patent expiration supports the prediction that heavily insured markets experience little or no efficiency loss under monopoly, while less insured markets exhibit behavior more consistent with the standard theory of monopoly.

Entities:  

Year:  2013        PMID: 23997354      PMCID: PMC3752927          DOI: 10.1016/j.jpubeco.2013.03.001

Source DB:  PubMed          Journal:  J Public Econ        ISSN: 0047-2727


  5 in total

1.  Innovation and The Welfare Effects of Public Drug Insurance.

Authors:  Darius Lakdawalla; Neeraj Sood
Journal:  J Public Econ       Date:  2009-04-01

2.  Market power, monopsony, and health insurance markets.

Authors:  M V Pauly
Journal:  J Health Econ       Date:  1988-06       Impact factor: 3.883

3.  Contracting with limited commitment: evidence from employment-based health insurance contracts.

Authors:  Keith J Crocker; John R Moran
Journal:  Rand J Econ       Date:  2003

4.  Competition and market power in option demand markets.

Authors:  Cory Capps; David Dranove; Mark Satterthwaite
Journal:  Rand J Econ       Date:  2003

5.  Competition among hospitals.

Authors:  Martin Gaynor; William B Vogt
Journal:  Rand J Econ       Date:  2003
  5 in total
  1 in total

1.  The economics of alternative payment models for pharmaceuticals.

Authors:  Jakub P Hlávka; Jeffrey C Yu; Dana P Goldman; Darius N Lakdawalla
Journal:  Eur J Health Econ       Date:  2021-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.